Bangladesh vs Yemen: Access to anti-retroviral drugs, female
Bangladesh
33.0%
in 2024
Yemen
34.0%
in 2024
Bangladesh rank
133rd
Yemen rank
132nd
Access to anti-retroviral drugs, female over time
- Bangladesh
- Yemen
How they compare
Yemen currently reports 34.0% against 33.0% in Bangladesh, a difference of 1.0%.
The two have swapped places 4 times across 25 shared years of data; in 2000 it was Yemen ahead.
Bangladesh ranks 133rd and Yemen ranks 132nd of 141 countries.
Across the 3 decades both report, Bangladesh averaged higher in 1 and Yemen in 2.
Head to head by decade
| Decade | Bangladesh | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 1.1% | 0.6% | Bangladesh |
| 2010s | 16.0% | 18.5% | 2.5% | Yemen |
| 2020s | 30.0% | 31.2% | 1.2% | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bangladesh or Yemen?
- Yemen, at 34.0% against 33.0% in Bangladesh as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bangladesh and Yemen?
- 1.0%, with Yemen ahead.
- How many years of comparable data are there for Bangladesh and Yemen?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Yemen rank globally for access to anti-retroviral drugs, female?
- Bangladesh ranks 133rd and Yemen ranks 132nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.